methionine has been researched along with Spinal Cord Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatazawa, J; Itoh, Y; Kowada, M; Mineura, K; Ogawa, T; Sasajima, T; Uemura, K | 1 |
| Barrington, SF; Bullock, P; Cox, T; Maisey, M; Pritchard, D; Robinson, RO; Wilmshurst, JM | 1 |
2 other study(ies) available for methionine and Spinal Cord Neoplasms
| Article | Year |
|---|---|
Spinal cord ependymoma: a positron emission tomographic study with (11C-methyl)-L-methionine.
Topics: Aged; Carbon Radioisotopes; Ependymoma; Humans; Male; Methionine; Spinal Cord; Spinal Cord Neoplasms; Tissue Survival; Tomography, Emission-Computed | 1996 |
Positron emission tomography in imaging spinal cord tumors.
Topics: Adolescent; Adult; Carbon Radioisotopes; Child; Child, Preschool; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Infant; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Neoplasm, Residual; Radiotherapy, Adjuvant; Sensitivity and Specificity; Spinal Cord; Spinal Cord Neoplasms; Tomography, Emission-Computed | 2000 |